Jeffrey W. Corbett
Pfizer (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Quinazolinone synthesis and applications, HIV Research and Treatment, Alkaloids: synthesis and pharmacology, Chemical Synthesis and Analysis
Most-Cited Works
- → Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors(2000)300 cited
- → Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1(1999)119 cited
- → Solid-Phase Synthesis of Benzopiperazinones(1998)88 cited
- → Facile Preparation of 2,6-Disubstituted Purines Using Solid-Phase Chemistry(1997)78 cited
- → Solid-phase synthesis of a selective αvβ3 integrin antagonist library(1997)69 cited
- → Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus(2011)68 cited
- → Applications of Vinylogous Mannich Reactions. Asymmetric Synthesis of the Heteroyohimboid Alkaloids (-)-Ajmalicine, (+)-19-epi-Ajmalicine, and (-)-Tetrahydroalstonine(1995)61 cited
- → Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2(2009)58 cited
- → Maximizing Lipophilic Efficiency: The Use of Free-Wilson Analysis in the Design of Inhibitors of Acetyl-CoA Carboxylase(2011)54 cited
- → The Stereochemical Course of Nucleophilic Additions of 2-Trialkylsiloxyfurans to CyclicN-Acyliminium Ions(1992)53 cited